At a glance
ClinicalIndex Comparison RecordN/ACompleted· 251 enrolled
Drug / intervention
Corus CADother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
In Brief
An observational study evaluating Corus CAD for Chest Pain and 7 related conditions. Completed, enrolled 251 participants across 4 sites.
Detailed Summary
This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChest Pain, Cardiovascular Diseases, Angina Pectoris, Coronary Artery Disease, CAD, CVD, CHD, Coronary Heart Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedMay 2012
Primary CompletionJan 2013
Study CompletionFeb 2013
TodayJul 2026
First PostedMay 9, 2012
Enrollment StartApr 1, 2012
Primary CompletionJan 1, 2013
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.1 years ago
Interventions
Corus CADother
Age/Sex/Gene Expression Score (ASGES)